Skip to Main Navigation
Skip to Page Content

Nomination Summary for Sulfamethizole (N85104)

Nominated Substances: Sulfamethizole

Nomination Date: 10/22/1984

Nominator: NCI

Rationale: Sulfamethizole has produced a low incidence of sarcomas in preliminary studies in mice. It is believed to have considerable potential for human exposure based on its use as a major sulfa drug in the treatment of urinary tract infections.

NTP Principles: Pre 1993 - 6,

Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.

CASRN: 144-82-1

Agent Name: Sulfamethizole